Published in Br Dent J on December 11, 2004
A systematic review of the use of theory in randomized controlled trials of audit and feedback. Implement Sci (2013) 1.32
The translation research in a dental setting (TRiaDS) programme protocol. Implement Sci (2010) 1.19
Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel) (2016) 0.86
Practice change toward better adherence to evidence-based treatment of early dental decay in the National Dental PBRN. Implement Sci (2014) 0.80
Evaluating the impact of caries prevention and management by caries risk assessment guidelines on clinical practice in a dental teaching hospital. BMC Oral Health (2016) 0.75
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
Life with 6000 genes. Science (1996) 41.51
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess (2004) 29.45
Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1984) 20.61
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev (1987) 7.00
Internists' attitudes about clinical practice guidelines. Ann Intern Med (1994) 6.55
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci U S A (2001) 5.19
Inability of trained nurses to perform basic life support. Br Med J (Clin Res Ed) (1987) 5.08
Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev (2002) 4.75
Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast. Yeast (1996) 4.53
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med (1997) 4.47
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care (2003) 4.46
Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res (2001) 4.22
Function and regulation of yeast hexose transporters. Microbiol Mol Biol Rev (1999) 3.96
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Three different regulatory mechanisms enable yeast hexose transporter (HXT) genes to be induced by different levels of glucose. Mol Cell Biol (1995) 3.74
Two glucose transporters in Saccharomyces cerevisiae are glucose sensors that generate a signal for induction of gene expression. Proc Natl Acad Sci U S A (1996) 3.54
Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (1991) 3.41
Disability: a model and measurement technique. Br J Prev Soc Med (1976) 3.41
The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol (2007) 3.34
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. Clin Oncol (R Coll Radiol) (2002) 3.33
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression. Proc Natl Acad Sci U S A (1991) 3.00
Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J (1997) 2.97
Regulated nuclear translocation of the Mig1 glucose repressor. Mol Biol Cell (1997) 2.96
Glucose sensing and signaling by two glucose receptors in the yeast Saccharomyces cerevisiae. EMBO J (1998) 2.96
The fate of 1,587 unrestored carious deciduous teeth: a retrospective general dental practice based study from northern England. Br Dent J (2002) 2.92
Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (2006) 2.72
Genetic evidence that zinc is an essential co-factor in the DNA binding domain of GAL4 protein. Nature (1987) 2.71
Development of the human coagulation system in the full-term infant. Blood (1987) 2.69
Systematic reviews of the effectiveness of quality improvement strategies and programmes. Qual Saf Health Care (2003) 2.69
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technol Assess (2008) 2.68
Two systems of glucose repression of the GAL1 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.65
Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med (2001) 2.35
GRR1 of Saccharomyces cerevisiae is required for glucose repression and encodes a protein with leucine-rich repeats. Mol Cell Biol (1991) 2.34
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
The work of a clinical psychologist in primary care. J R Coll Gen Pract (1978) 2.31
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics (1998) 2.27
The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess (2007) 2.27
Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (2005) 2.25
Baseline staging tests in primary breast cancer: a practice guideline. CMAJ (2001) 2.22
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Adult Dental Health Survey 2009: common oral health conditions and their impact on the population. Br Dent J (2012) 2.12
tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10
Predictors of emotional outcomes of intensive care. Anaesthesia (2005) 2.10
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev (2006) 2.07
The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom Res (1989) 2.06
Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev (2008) 2.04
Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene (1989) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
An analysis of patient expenditure in the GDS in Scotland 1998-2007. Br Dent J (2011) 2.02
Two zinc-finger-containing repressors are responsible for glucose repression of SUC2 expression. Mol Cell Biol (1996) 1.92
Maturation of the hemostatic system during childhood. Blood (1992) 1.89
The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae. Curr Biol (1999) 1.89
Mutations that inactivate a yeast transcriptional regulatory protein cluster in an evolutionarily conserved DNA binding domain. Proc Natl Acad Sci U S A (1987) 1.86
Rgt1p of Saccharomyces cerevisiae, a key regulator of glucose-induced genes, is both an activator and a repressor of transcription. Mol Cell Biol (1996) 1.85
TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 1.80
Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol (1990) 1.78
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ (2001) 1.71
Does motor imagery training improve hand function in chronic stroke patients? A pilot study. Clin Rehabil (2004) 1.69
Routine scale and polish for periodontal health in adults. Cochrane Database Syst Rev (2005) 1.64
Analysis of URSG-mediated glucose repression of the GAL1 promoter of Saccharomyces cerevisiae. Genetics (1992) 1.64
Molecular cloning of the GAL80 gene from Saccharomyces cerevisiae and characterization of a gal80 deletion. Gene (1984) 1.64
How to influence patient oral hygiene behavior effectively. J Dent Res (2009) 1.63
Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res (1988) 1.60
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. BJOG (2008) 1.58
Development of the human coagulation system in the healthy premature infant. Blood (1988) 1.57
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Isolation and characterization of the ZWF1 gene of Saccharomyces cerevisiae, encoding glucose-6-phosphate dehydrogenase. Gene (1990) 1.57
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood (1992) 1.55
The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn (1992) 1.53
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood (1993) 1.52
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. Eur Heart J (2002) 1.51
Expression of the SUC2 gene of Saccharomyces cerevisiae is induced by low levels of glucose. Yeast (1997) 1.49
Frequency and mechanism of neonatal thrombocytopenia. J Pediatr (1986) 1.49
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med (2004) 1.48
Screening for Down's syndrome. BMJ (1988) 1.48
A tuberculin skin test survey among Afghan children in Kabul. Int J Tuberc Lung Dis (2004) 1.47
Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gamma-lyase during processing of L-propargylglycine. Biochemistry (1979) 1.47
Current practices and intention to provide alcohol-related health advice in primary dental care. Br Dent J (2011) 1.46
Sources of support and the physical and mental well-being of young women with breast cancer. Soc Sci Med (2001) 1.44
Temporary elective tooth separation as a diagnostic aid in general dental practice. Br Dent J (1990) 1.44
An unusual case of prolonged tinnitus following low-dose amitriptyline. J Psychopharmacol (2008) 1.44
The dental caries experience of 5-year-old children in Great Britain (2005/6). Surveys co-ordinated by the British Association for the study of community dentistry. Community Dent Health (2007) 1.43
Manual versus powered toothbrushing for oral health. Cochrane Database Syst Rev (2005) 1.43
The orthodontic condition of children in the United Kingdom, 2003. Br Dent J (2006) 1.42
Managing patients on bisphosphonates: the practice of primary care dentists before and after the publication of national guidance. Br Dent J (2014) 1.42
Suppressors reveal two classes of glucose repression genes in the yeast Saccharomyces cerevisiae. Genetics (1994) 1.42
Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev (2002) 1.42